2.Rescuing Bombyx mori bidensovirus in BmN cells in vitro.
Miaomiao ZHANG ; Ying MA ; Xiaoli PAN ; Zhaoyang HU ; Guohui LI ; Yayun SI ; Yali XING ; Keping CHEN ; Qin YAO
Chinese Journal of Biotechnology 2015;31(1):86-95
Bombyx mori bidensovirus (BmBDV) has been identified as causing chronic densonucleosis in Bombyx mori specifically. The replication mechanism of BmBDV remains unknown. Its genome comprises two single stands DNA (VD1 and VD2). In order to rescue infectious virions in vitro, we obtained the total viral DNA extracted from the BmBDV-infected larvae midguts, subsequently cloned the full-length sequence of BmBDV genome fragments by PCR and constructed recombinant plasmids pMD18T-VD1 and pUC-VD2. The linear genome fragments were obtained by digesting recombinant plasmids with corresponding restriction enzymes, and then collectively transfected BmN cells by the method of liposome-embedding. We determined the replication of the virus gene by PCR with the template of demethylated total DNA extracted from the post-transfect BmN cells. Meanwhile, we collected the total proteins from the post-transfect BmN cells and the larvae midgut of feeding the post-transfect BmN cells to perform Western blotting analysis, and detected the expression of viral genes. Here we firstly confirm that infectious virions can be rescued in BmN cells by linear co-transfect method.
Animals
;
Bombyx
;
DNA, Viral
;
Densovirus
;
growth & development
;
Larva
;
Transfection
;
Virion
;
Virus Cultivation
3.Disease burden of influenza in children and current status of vaccine usage in China
Muli ZHANG ; Zhibin PENG ; Jiandong ZHENG ; Yayun TAN ; Xuan WANG ; Ying QIN ; Luzhao FENG
Chinese Journal of Applied Clinical Pediatrics 2019;34(2):91-97
The annual deaths associated with influenza is estimated to be between 290 000 and 650 000,which caused substantial burden to the society.Children have the highest incidence of influenza among all age groups,which can cause overloaded medical visits and a significant increase of hospitalization risk.The severe economic burden includes not only the direct medical costs due to outpatients and hospitalization,but also the indirect burden of school absence of children and work absence of their family members.Annual vaccination is the best measure to prevent influenza,however,influenza vaccination coverage among children in China is very low,and influenza vaccination has not yet been included in the National Immunization Program.Now,the disease burden of influenza and the vaccine usage in children in China were reviewed,and in order to provide evidence for influenza control and prevention.
4.A survey on the condition of bike lanes in 12 cities, China
Yayun TAN ; Chenxi QIN ; Baojing LIANG ; Chaoqun WU ; Jun LYU ; Liming LI
Chinese Journal of Epidemiology 2015;36(4):304-308
Objective To explore the condition on bike lanes and the relationship with GDP of the related cities,residential of regions and prosperity of streets in 12 selected cities in China.Methods Eexistence and maintenance of bike lanes were examinedin in all the streets under survey in 333 blocks of 12 cities (Beijing,Tianjin,Shanghai,Qingdao,Hangzhou,Shaoxing,Suzhou,Nantong,Zhenjiang,Chengdu,Xining and Harbin).Data were collected on GDP of the related cities,together with the sizes of population and proportion of the 333 blocksand the numbers of stores and restaurants in those streets.Results A total of 4 202 streets were included in the study.In the 12 cities,32.6% of the streets were equipped with bike lanes.Bike-lane-equipmentsseemed better in Nantong (46.5%),Tianjin (39.6%) and Shanghai (39.4%),but the scores were lower in Xining (2.0%),Qingdao (5.4%),and Harbin (27.1%).The higher GDP was,the better bike lanes were equipped.In the meantime,the isolation of bike lanes were worse and the streets more crowded.Density of the residential area was negatively correlated with the score on bike lane-equipments.Conclusion Differences of the condition of bike lanes in the 12 cities indicated that improvement should be made on bike lanes.More attention should be paid to those cities with high GDPs and crowded residential regions on setting up the isolated bike lanes and reasonable equipments.
5.Genetic variation and distribution characteristics of thalassemia in people of childbearing age in Hubei Province
Runhong XU ; Hui LI ; Yayun QIN ; Yufei JIANG ; Meiqi YI ; Guoqiang SUN ; Miaomiao CHEN ; Jieping SONG
Chinese Journal of Endemiology 2023;42(4):280-285
Objective:To study the genetic variation and distribution characteristics of thalassemia in people of childbearing age in Hubei Province, and to provide clinical basis for the local government decision-making departments to formulate and promote appropriate policies for prevention and control of thalassemia.Methods:Venous blood samples were collected from 44 849 people of childbearing age in hospitals in Hubei Province from May 13, 2019 to August 17, 2021. PCR-flow fluorescence hybridization and PCR+diversion hybridization were used to screen thalassemia genes. Spouses of those who tested positive were also tested for thalassemia genes. When both spouses carried the same type of thalassemia gene, the amniotic fluid of pregnant women was extracted for prenatal diagnosis and followed up.Results:Among the 44 849 people of childbearing age, 2 286 cases were diagnosed as thalassemia gene carriers through genetic testing, and the total detection rate was 5.10% (2 286/44 849). Among them, 1 488 cases were diagnosed as α-thalassemia, and the detection rate was 3.32% (1 488/44 849); 767 cases were diagnosed as β-thalassemia, and the detection rate was 1.71% (767/44 849); 31 cases were diagnosed as α-thalassemia combined with β-thalassemia, and the detection rate was 0.07% (31/44 849). The top three genotypes of α-thalassemia were -α 3.7/αα, -- SEA/αα, and -α 4.2/αα, accounting for 58.06% (864/1 488), 26.14% (389/1 488), and8.74% (130/1 488), respectively. The top three genotypes of β-thalassemia were β IVS-Ⅱ-654/β N, β CD41-42/β N, and β CD17/β N, accounting for 41.72% (320/767), 21.25% (163/767), and 16.04% (123/767), respectively. The main genotypes of α-thalassemia combined with β-thalassemia were -α 3.7/αα complex β IVS-Ⅱ-654/β N and -α 3.7/αα complex β CD41-42/β N, accounting for 29.03% (9/31) and 16.13% (5/31), respectively. A total of 59 people of childbearing age were conducted prenatal diagnosis, among fetus, there were 4 cases of severe thalassemia (2 cases of severe α-thalassemia, 2 cases of severe β-thalassemia), 5 cases of intermediate α-thalassemia, 5 cases of intermediate or severe β-thalassemia, 19 cases of mild thalassemia (8 cases of mild α-thalassemia, 11 cases of mild β-thalassemia), 13 cases of stationary α-thalassemia, and 1 case of stationary α-thalassemia combined with mild β-thalassemia, there were 12 cases without α-thalassemia or β-thalassemia genes. After follow-up, 4 cases of severe thalassemia, 2 cases of intermediate α-thalassemia, and 5 cases of intermediate or severe β-thalassemia were terminated pregnancy by the joint decision of both parents. Conclusions:In Hubei Province, the detection rate of thalassemia is high, and α-thalassemia is the main mutation type. The combination of thalassemia gene screening and prenatal diagnosis is of great significance in reducing the birth rate of children with thalassemia.
6. Technical guidelines for seasonal influenza vaccination in China (2018-2019)
Luzhao FENG ; Zhibin PENG ; Dayan WANG ; Peng YANG ; Juan YANG ; Yanyang ZHANG ; Jian CHEN ; Shiqiang JIANG ; Lili XU ; Min KANG ; Tao CHEN ; Yaming ZHENG ; Jiandong ZHENG ; Ying QIN ; Mengjiao ZHAO ; Yayun TAN ; Zhongjie LI ; Zijian FENG
Chinese Journal of Preventive Medicine 2018;52(11):1101-1114
Seasonal influenza vaccination is the most effective way to prevent influenza virus infection and complications from infection. Currently, China has licensed trivalent inactivated influenza vaccine (IIV3) and quadrivalent inactivated influenza vaccine (IIV4), including split-virus influenza vaccine and subunit vaccine. Except for a few major cities, influenza vaccine is a category Ⅱ vaccine, which means influenza vaccination is voluntary, and recipients must pay for it. To strengthen the technical guidance for prevention and control of influenza and operational research on influenza vaccination in China, the National Immunization Advisory Committee (NIAC) Influenza Vaccine Technical Working Group (TWG), updated the 2014 technical guidelines and compiled the "Technical guidelines for seasonal influenza vaccination in China (2018-2019)" . The main updates in this version include: epidemiology, disease burden, types of influenza vaccines, northern hemisphere influenza vaccination composition for the 2018-2019 season, IIV3 and IIV4 immune response, durability of immunity, immunogenicity, vaccine efficacy, effectiveness, safety, cost-effectiveness and cost-benefit. The influenza vaccine TWG provided the recommendations for influenza vaccination for the 2018-2019 influenza season based on existing scientific evidence. The recommendations described in this report include the following: Points of Vaccination clinics (PoVs) should provide influenza vaccination to all persons aged 6 months and above who are willing to be vaccinated and do not have contraindications. No preferential recommendation is made for one influenza vaccine product over another for persons for whom more than one licensed, recommended, and appropriate product is available. To decrease the risk of severe infections and complications due to influenza virus infection among high risk groups, the recommendations prioritize seasonal influenza vaccination for children aged 6-59 months, adults ≥60 years of age, persons with specific chronic diseases, healthcare workers, the family members and caregivers of infants <6 months of age, and pregnant women or women who plan to become pregnant during the influenza season. Children aged 6 months through 8 years require 2 doses of influenza vaccine administered a minimum of 4 weeks apart during their first season of vaccination for optimal protection. If they were vaccinated in 2017-2018 influenza season or a prior season, 1 dose is recommended. People more than 8 years old require 1 dose of influenza vaccine. It is recommended that people receive their influenza vaccination by the end of October. Influenza vaccination should be offered as soon as the vaccination is available. For the people unable to be vaccinated before the end of October, influenza vaccination will continue to be offered for the whole season. Influenza vaccine is also recommended for use in pregnant women during any trimester. These guidelines are intended for use by staff members of the Centers for Disease Control and Prevention at all levels who work on influenza control and prevention, PoVs staff members, healthcare workers from the departments of pediatrics, internal medicine, and infectious diseases, and staff members of maternity and child care institutions at all levels.
7. Evaluation of the application of moving epidemic method on making influenza epidemic thresholds in the 7 climate zones in China
Yayun TAN ; Lingjia ZENG ; Ying QIN ; Jiandong ZHENG ; Zhongjie LI ; Dayan WANG ; Tao CHEN ; Luzhao FENG ; Zhibin PENG
Chinese Journal of Preventive Medicine 2019;53(10):1007-1011
Objective:
We planned to evaluate the effectiveness of moving epidemic method (MEM) in calculating influenza epidemic threshold of 7 climatic zones in China mainland.
Methods:
The positive rate of influenza virus was obtained from the National Influenza Surveillance Network System from 2010/2011 to 2017/2018. We divided the 31 provinces into 7 climatic zones according to previous literatures and applied MEM to calculate the influenza epidemic threshold of 2018/2019 influenza season for these climatic zones. Sensitivity, specificity, positive predictive value and negative predictive value were calculated to evaluate the effectiveness of MEM.
Results:
Pre-epidemic threshold (the positive rate of influenza virus) varied from 9.66% (temperate zone) to 16.36% (subtropical zone) for 2018/2019 influenza season. The gap between pre-epidemic and post-epidemic thresholds was less than 5% except for plateau zone. The sensitivity was 86.16% (95
8.28-hydroxy-3-oxoolan-12-en-2-oic acid and miR-451 synergistically inhibit the proliferation and migration of gastric cancer AGS cells and its possible mechanism
SUN Hui ; HUA Weiwei ; CHEN Xiwen ; LI Yajuan ; QIN Wei ; YIN Zixin ; ZHAO Ya ; LIU Yanqing ; QIAN Yayun
Chinese Journal of Cancer Biotherapy 2021;28(11):1081-1086
[摘 要] 目的:探索南蛇藤提取物齐墩果烷型五环三萜(28-hydroxy-3-oxoolean-12-en-2-oic acid)协同miR-451对人胃癌AGS细胞增殖、迁移的影响及其可能的分子机制。方法:用miR-451过表达慢病毒感染AGS细胞,并用盐酸多西环素(DOX)10或100 ng/ml诱导24 h,构建过表达miR-451的细胞AGS/miR-451+。采用10、20、40、80、160 μmol/L的齐墩果烷型五环三萜处理AGS/miR-451+细胞,MTT法、划痕实验分别检测细胞增殖和迁移能力的变化,WB法检测细胞中mTOR通路及凋亡相关蛋白表达水平的变化。结果:成功构建过表达miR-451的AGS/miR-451+细胞。与未加药对照组相比,齐墩果烷型五环三萜处理后AGS/miR-451+细胞的增殖抑制率均呈时间和浓度依赖性升高(P<0.05或P<0.01),细胞迁移率均显著降低(P<0.05或P<0.01)。齐墩果烷型五环三萜处理组细胞中,mTOR 信号通路相关蛋白的表达量均有所降低(P<0.05或P<0.01);凋亡相关蛋白中,Bcl2的表达量下降,BAX、caspase-3、caspase-1及细胞色素c的表达量升高(P<0.05或P<0.01)。结论:齐墩果烷型五环三萜能够协同miR-451抑制人胃癌AGS细胞的增殖与迁移,其机制可能与影响凋亡和mTOR信号通路相关蛋白的表达有关。